Bausch Health Companies | VRX - Acreedores Comerciales

Precio De Mercado
7.31
Cambio Diario
-0.19 -2.53%
Mensual
0.83%
Anual
6.56%
Q2 Expectativa
7.29




Acreedores Comerciales Cambio Fecha
Amgen USD 20.89B 1.25B 2025-12
ANI Pharmaceuticals USD 62.58M 7.21M 2025-12
Aurora Cannabis CAD 68.03M 18.68M 2025-12
Bausch Health Companies USD 600M 16M 2025-12
Biogen USD 432M 18.9M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Canopy Growth CAD 19.96M 1.83M 2025-12
Corcept Therapeutics USD 40.44M 6M 2025-12
Danaher USD 1.84B 147M 2025-12
Drreddys Laboratories INR 454.04M 854K 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Gilead Sciences USD 808M 226M 2025-09
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Novo Nordisk DKK 19.76B 4.15B 2025-12
Pacira USD 15.15M 2.54M 2025-12
Perrigo USD 474.5M 4.8M 2025-12
Phibro Animal Health USD 133.3M 2.7M 2025-12
Prestige Brands USD 42.95M 1.02M 2025-12
Supernus Pharmaceuticals USD 107.8M 813K 2025-12
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12
Zoetis USD 487M 77M 2025-12